Texas A&M University’s National Center for Therapeutics Manufacturing provides trainees, faculty, academics, and industry partners with an engaging learning atmosphere. The modular and versatile clinical manufacturing platforms in the 104,000 square foot bioprocess wing will accommodate all aspects of scientific drug products, including vaccines, monoclonal antibodies, cellular and gene therapies therapeutics.